Eltenac

• CAT Number: R047771
• CAS Number: 72895-88-6
• Molecular Formula: C12H9Cl2NO2S
• Molecular Weight: 302.169
• Purity: ≥95%
• Synonyms: 4-[(2,6-Dichlorophenyl)amino]-3-thiopheneacetic Acid; 4-(2,6-Dichloroanilino)-3-?thiopheneacetic Acid; Telzenac; [4-(2,6-Dichlorophenylamino)thiophen-3-yl]acetic Acid
• Target: COX
• Storage: -20°C
• IUPAC Name: 2-[4-(2,6-dichloroanilino)thiophen-3-yl]acetic acid
• InChI: InChI=1S/C12H9Cl2NO2S/c13-8-2-1-3-9(14)12(8)15-10-6-18-5-7(10)4-11(16)17/h1-3,5-6,15H,4H2,(H,16,17)
• InChIKey: AELILMBZWCGOSB-UHFFFAOYSA-N
• SMILES: C1=CC(=C(C(=C1)Cl)NC2=CSC=C2CC(=O)O)Cl

Eltenac is a non-steroidal anti-inflammatory drug (NSAID) used in veterinary medicine, primarily for treating inflammation and pain associated with musculoskeletal disorders. It works by inhibiting the cyclooxygenase (COX) enzymes, which are involved in the production of prostaglandins that cause pain and inflammation. Eltenac’s selective inhibition of COX-2 helps reduce inflammation while minimizing gastrointestinal side effects typically seen with non-selective NSAIDs. This compound is significant for research in veterinary pharmacology and is used to study anti-inflammatory and analgesic treatments in animals, particularly for conditions like arthritis and other inflammatory joint diseases.